JP Morgan Chase’s Syneron Medical Ltd ELOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-16,601
| Closed | -$182K | – | 5397 |
|
|
2017
Q2 | $182K | Buy |
+16,601
| New | +$182K | ﹤0.01% | 4012 |
|
|
2017
Q1 | – | Sell |
-5,540
| Closed | -$47K | – | 5376 |
|
|
2016
Q4 | $47K | Sell |
5,540
-6,923
| -56% | -$54.3K | ﹤0.01% | 4575 |
|
|
2016
Q3 | $89K | Sell |
12,463
-2,614,519
| -100% | -$18.2M | ﹤0.01% | 3894 |
|
|
2016
Q2 | $20.2M | Sell |
2,626,982
-38,171
| -1% | -$272K | 0.01% | 1389 |
|
|
2016
Q1 | $19.5M | Sell |
2,665,153
-173,968
| -6% | -$1.25M | 0.01% | 1355 |
|
|
2015
Q4 | $21.9M | Buy |
2,839,121
+28,751
| +1% | +$219K | 0.01% | 1262 |
|
|
2015
Q3 | $20.1M | Sell |
2,810,370
-110,630
| -4% | -$1.06M | 0.01% | 1253 |
|
|
2015
Q2 | $31M | Buy |
2,921,000
+22,101
| +0.8% | +$259K | 0.01% | 1147 |
|
|
2015
Q1 | $35.9M | Buy |
2,898,899
+822,245
| +40% | +$9.1M | 0.01% | 1058 |
|
|
2014
Q4 | $19.4M | Sell |
2,076,654
-180,273
| -8% | -$1.74M | ﹤0.01% | 1492 |
|
|
2014
Q3 | $22.6M | Sell |
2,256,927
-24,874
| -1% | -$253K | 0.01% | 1372 |
|
|
2014
Q2 | $23.5M | Sell |
2,281,801
-164,595
| -7% | -$1.78M | 0.01% | 1241 |
|
|
2014
Q1 | $30.5M | Buy |
2,446,396
+45,739
| +2% | +$542K | 0.01% | 1089 |
|
|
2013
Q4 | $29.5M | Sell |
2,400,657
-4,320
| -0.2% | -$44.9K | 0.01% | 1089 |
|
|
2013
Q3 | $20.7M | Sell |
2,404,977
-1,100
| -0% | -$9.49K | 0.01% | 1306 |
|
|
2013
Q2 | $20.9M | Buy |
+2,406,077
| New | +$21.5M | 0.01% | 1223 |
|
Other funds holding ELOS
JP Morgan Chase's ELOS Position: Q3 2017 in Review
JP Morgan Chase sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 16,601 shares — an estimated $182K sold.
JP Morgan Chase first reported a position in ELOS in Q2 2013 and held it in 16 quarters. The position peaked at $35.9M in Q1 2015. 3 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.
- JP Morgan Chase reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
- JP Morgan Chase sold 16,601 Syneron Medical Ltd shares in Q3 2017, an estimated $182K.
- JP Morgan Chase first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 16 quarters.
- JP Morgan Chase's Syneron Medical Ltd position peaked at $35.9M in Q1 2015.
- 3 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.
Based on JP Morgan Chase's 13F filing for Q3 2017, filed 9 Nov 2017.